WCM Investment Management
JAZZ icon

WCM Investment Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

WCM Investment Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-3,500
Closed -$562K – 116
2014
Q3 		$562K Hold
3,500
– – 0.02% 94
2014
Q2 		$515K Hold
3,500
– – 0.01% 118
2014
Q1 		$485K Hold
3,500
– – 0.02% 115
2013
Q4 		$443K Hold
3,500
– – 0.02% 110
2013
Q3 		$322K Hold
3,500
– – 0.02% 119
2013
Q2 		$241K Buy
+3,500
New +$214K 0.01% 135

Other funds holding JAZZ

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
WBC
Westpac Banking Corp Sydney, Australia $1.44B AUM 28.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WCM Investment Management's JAZZ Position: Q4 2014 in Review

WCM Investment Management sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2014, closing a stake of 3,500 shares — an estimated $562K sold.

WCM Investment Management first reported a position in JAZZ in Q2 2013 and held it in 6 quarters. The position peaked at $562K in Q3 2014. 357 funds tracked by Wall St. Rank hold JAZZ as of Q4 2014.

  • WCM Investment Management reported no remaining Jazz Pharmaceuticals position as of Q4 2014 after selling out during the quarter.
  • WCM Investment Management sold 3,500 Jazz Pharmaceuticals shares in Q4 2014, an estimated $562K.
  • WCM Investment Management first reported a position in Jazz Pharmaceuticals in Q2 2013 and held it in 6 quarters.
  • WCM Investment Management's Jazz Pharmaceuticals position peaked at $562K in Q3 2014.
  • 357 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2014.

Based on WCM Investment Management's 13F filing for Q4 2014, filed 9 Feb 2015.